Please note: The conference will be held in person, and there will be no hybrid option available.

Join us for MIDD+ Shanghai!

Spend a full day diving deeper into the world of model-informed drug development (MIDD). This event brings together leaders and innovators from across the industry for engaging presentations and interactive training sessions alongside industry peers.

Discover practical insights from experts who will showcase how MIDD is transforming drug development, with real-world case studies powered by Simulations Plus technology. Our scientists will guide hands-on workshops designed to strengthen your expertise and introduce new ways to apply these approaches in your own work.

Presentations Include:

• Effective FDA Communication Strategies for MIDD: Accelerating Dosage Regimen Selection and Optimization for Project Success | Susie Zhang, Simulations Plus
  
• ICH M15 and PopPK-PD Analysis SOP | Zheng Jiao, Shanghai Chest Hospital
• FDA MIDD: 2015-2025 NDA/BLA Regulatory Trends & Case Studies | Yuan Xu, Daiichi Sankyo
• Application of MIDD in Early Clinical Dosage Regimen Selection | Wen Jun Chen, The Second Affiliated Hospital Zhejiang University
• Dose Regimens Selection using PBPK Modeling & Case Studies | Haiying Zhou, Simulations Plus
• Application of MIDD in Clinical Development of Adeno-Associated Virus Gene Therapy | Peng Zou, Ultragenyx Pharma